Oncogenomics: The Driver of Clinical Utility

May 11, 2021

Moderator: Alex Aravanis, Illumina
Panelists: Christina Curtis, Stanford University; Joel Dudley, Tempus; Elli Papaemmanuil, Memorial Sloan Kettering Cancer Center
Description: As methods to analyze a wealth of genomic data evolve, the promise of precision medicine in oncology moves into reality. This panel of oncogenomics experts share advances on the cutting edge of oncogenomics research and translation into the clinic.

SPARK is a global idea forum that shines a light on the leaders, thinkers, and innovators collaborating to make precision healthcare a reality.

Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.

*Data calculations on file. Illumina, Inc., 2015.

View customer spotlight videos

View Illumina webinars

View Illumina product videos

View Illumina support videos

Share this article on